BIRATTARI, CLAUDIO CARMELO
 Distribuzione geografica
Continente #
NA - Nord America 3.732
EU - Europa 3.488
AS - Asia 2.893
Continente sconosciuto - Info sul continente non disponibili 541
SA - Sud America 236
AF - Africa 52
OC - Oceania 3
Totale 10.945
Nazione #
US - Stati Uniti d'America 3.634
GB - Regno Unito 1.218
CN - Cina 901
SG - Singapore 896
IT - Italia 710
DE - Germania 304
SE - Svezia 293
RU - Federazione Russa 292
HK - Hong Kong 209
IN - India 181
TR - Turchia 176
UA - Ucraina 160
VN - Vietnam 159
BR - Brasile 140
KR - Corea 137
FR - Francia 135
FI - Finlandia 102
BD - Bangladesh 101
NL - Olanda 92
IE - Irlanda 89
EU - Europa 68
CA - Canada 60
CO - Colombia 31
JP - Giappone 31
GR - Grecia 23
AR - Argentina 22
ZA - Sudafrica 19
BE - Belgio 16
MX - Messico 14
VE - Venezuela 14
ID - Indonesia 13
AT - Austria 11
SA - Arabia Saudita 11
EC - Ecuador 10
IQ - Iraq 10
ES - Italia 9
PH - Filippine 9
DK - Danimarca 8
PK - Pakistan 8
PL - Polonia 8
JM - Giamaica 7
MY - Malesia 7
CI - Costa d'Avorio 6
CL - Cile 5
IR - Iran 5
KE - Kenya 5
TH - Thailandia 5
UY - Uruguay 5
UZ - Uzbekistan 5
EG - Egitto 4
PT - Portogallo 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
CR - Costa Rica 3
HN - Honduras 3
JO - Giordania 3
MA - Marocco 3
OM - Oman 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
GH - Ghana 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
Totale 10.470
Città #
Southend 1.108
Ann Arbor 563
Singapore 552
Ashburn 239
Chandler 232
Santa Clara 216
San Jose 206
Hong Kong 203
Milan 186
Beijing 174
Council Bluffs 160
Seattle 158
Princeton 150
Mountain View 115
Wilmington 104
Dallas 102
Jacksonville 94
Redmond 91
Dublin 87
Phoenix 72
Los Angeles 69
Nanjing 69
New York 68
Kent 67
Boardman 63
Bengaluru 62
Sakarya 61
Lauterbourg 54
Buffalo 53
Des Moines 53
Ho Chi Minh City 44
Moscow 43
Dearborn 41
Shanghai 40
Serra 37
Helsinki 35
Somerville 30
Rome 29
Andover 27
Bogotá 27
Grafing 27
Hanoi 26
Hefei 25
Tokyo 25
Fuzhou 24
Athens 23
Guangzhou 23
Hangzhou 23
Fairfield 21
Jinan 21
Shenyang 21
Eitensheim 19
Nanchang 18
Woodbridge 18
Medford 17
Tianjin 17
Changsha 16
Dong Ket 16
Toronto 16
Turin 16
Hebei 15
Brussels 14
Cangzhou 14
Frankfurt am Main 14
Houston 14
Shenzhen 14
Jiaxing 11
Munich 11
Nuremberg 11
Palermo 11
São Paulo 11
Zhengzhou 11
Lanzhou 10
Naples 10
Redwood City 10
Bologna 9
Falkenstein 9
Florence 9
Montreal 9
Wuhan 9
Bari 8
Johannesburg 8
Trieste 8
Atlanta 7
Caracas 7
Ningbo 7
Prato 7
Quanzhou 7
San Diego 7
Abidjan 6
Auburn Hills 6
Boston 6
Cape Town 6
Chicago 6
Columbus 6
Cornate D'adda 6
Da Nang 6
Delhi 6
Haiphong 6
Hyderabad 6
Totale 6.554
Nome #
Analisi cromatografica di radiofarmaco marcato con beta emettitore (186g-Re) utilizzato per la terapia palliativa del dolore da metastasi ossee e sua biodistribuzione 378
Analytical and radioanalytical quality control of purity and stability of radiopharmaceutical compound Re-186 HEDP for bone metastases pain palliation. 326
Determinazione della purezza radionuclidica di [153Sm]Sm-EDTP(QuadrametTM), d’impiego nella terapia palliativa del dolore da metastasi ossee 310
Conceptual design of a high-brightness linac for soft X-ray SASE-FEL source 265
Neutron production from 40 GeV/c mixed proton/pion beam on copper, silver and lead targets in the angular range 30-135 degrees 259
Analytical and radioanalytical quality control in high specific activity radiotracer preparation 238
A rapid improved method for gamma spectrometry determination of thallium-202 impurities, in [thallium-201]labelled radiopharmaceuticals 227
A rapid improved method for gamma- spectrometric determination of 202Tl impurities, in [201Tl]-labelled radiopharmaceuticals 225
A competitive method for simultaneous deuteron-cyclotron production of No-Carrier-Added copper-64 and gallium-67,66 for applications in PET radiodiagnostic and metabolic therapy of tumours 222
A new method for N.C.A. copper-64 production 221
Optimisation study of a-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes 215
Study of a method based on TLD detectors for in-phantom dosimetry in BNCT 210
Thin-target excitation functions and optimisation of NCA Cu-64 and Ga-66,Ga-67 production by deuteron induced nuclear reactions on natural zinc target, for radiometabolic therapy and for PET 210
Comparison between theoretical calculation and experimental results of excitation functions for production of relevant biomedical radionuclides 204
Determination of I-125 impurities in [I-123]labelled radiopharmaceuticals, by liquid scintillation counting: sensitivity of the method 201
Thin-target excitation functions and optimization of simultaneous production of NCA copper-64 and gallium-66,67 by deuteron induced nuclear reactions on a natural zinc target 201
Fricke-gel dosimetry in Boron Neutron Capture Therapy 200
Copper-64 production studies with natural zinc targets at deuteron energy up to 19 MeV and proton energy from 141 down to 31 MeV 199
Detection of single and resonant projectile fragments in C-12-induced reactions to the continuum 198
On the high-resolution gamma-ray spectrometric measurement of 40K in natural and synthetic materials 196
Radioanalytical quality control on beta-emitting [186gRe]- and [153Sm]-radiopharmaceutical compounds for bone metastatses pain palliation 195
Study of light transmittance from layers of Fricke-xylenol-orange-gel dosimeters having different composition and analysed with variuos modalities. 193
Analisi farmacocinetiche e valutazioni dosimetriche su pazienti trattati con 186g-Re. 191
Cyclotron production, radiochemical separation and quality control of platinum radiotracers for toxicological studies 191
Influence of the chemical form on the plasma clearance of ruthenium in humans 184
Cyclotron production and quality control of "high specific activity" radionuclides in "no-carrier-added" form for radioanalytical applications in the life sciences 184
Stable tracer investigations in humans for assessing the biokinetics of ruthenium and zirconium radionuclides 179
Quantificazione in dosimetria planare con gammacamera : viste coniugate e calibrazione 178
Thin-target excitation functions: a powerful tool for optimising yield, specific activity and radionuclidic purity of accelerator-produced radionuclides 173
Analytical and radioanalytical quality control of purity and stability of radiopharmaceutical [186Re]HEDP for bone metastases pain palliation 169
Experimental results and model calculations of excitation functions relevant to the production of specific radioisotopes for metabolic radiotherapy and for PET 158
The radiochemistry laboratory of L.A.S.A. (Segrate): Technical description and legal aspects 156
Preparation of "high specific activity" radiochemical forms of vanadium, manganese and thallium for metallo-toxicological studies 154
Produzione con Ciclotrone, Separazioni Radiochimiche e Controlli di Qualità di Radiotraccianti ad elevata Attività Specifica per studi di tossicologia ambientale 153
Dosimetria midollo emopoietico durante trattamento con 153Sm-EDTMP : un metodo pratico basato solo sulla raccolta delle urine 152
Determination of arsenic in silicon matrices by proton activation analysis 149
A re-evaluation of the biokinetics of zirconium in humans 147
An absolute method for the energy calibration of cyclotron beams 147
Radiocesium contamination in soil due to the Chernobyl accident 143
Irradiation methods for production of high specific activity radionuclides in no carrier added form 139
Cyclotron production of Pt, Pd and Rh radiotracers to study the environmental impact of the catalytic converter emissions 135
Content of trace elements in the respirable fractions of the air particulate of urban and rural areas monitored by Neutron Activation Analysis 129
Optimization of irradiation system for on-line production and recovery of the generator for biomedical purposes 195m,195-Hg/195m-Au via Au(p,3n) nuclear reactions 127
Determination of 125I impurities in [123I]-labelled radiopharmaceuticals, by liquid scintillation counting: sensitivity of the method 127
Thin-target excitation functions, cross-sections and optimised thick-target yields for natMo(p,xn)94g,95m,95g,96(m+g)Tc nuclear reactions induced by protons from threshold up to 44 MeV. No Carrier Added radiochemical separation and quality control 121
Preparation of high specific activity radiotracers for radioanalytical studies 120
Simultaneous Cyclotron Production of No Carrier Added Copper-64 and Gallium-67 by Deuteron Induced Nuclear Reactions of Zinc Target: Thin- and Thick-target Yields, Radiochemical Separation, Quality Control 119
Cyclotron production of “No Carrier Added” platinum, palladium and rhodium radionuclides for metallo-toxicological studies 118
Cyclotron production of “very high specific activity” platinum radiotracers in No Carrier Added form 118
“High Specific Activity” radiotracers for metallo-toxicological studies: cyclotron and nuclear reactor production, radiochemical separation and quality control. Platinum, iridium, gold, copper and gallium 118
Cyclotron production of very high specific activity radionuclides for toxicological uses, at LASA-INFN: radiochemical separation and quality control 117
Thin target excitation functions for (alpha,xn) reactions on osmium targets for platinum radiotracer production 116
N.C.A. gold-199: a radionuclide suitable for both SPECT and radionuclide therapy: production yield, radiochemical separation, radionuclidic purity and specific activity 114
The biokinetics of ruthenium and zirconium radionuclides in humas studied with stabe tracers 114
High resolution gamma-spectrometry by HPGe detector and beta-spectrometry by liquid scintillation counting, hyphenated to elemental analysis techniques: applications of High Specific Activity radio-nuclides for ultra-trace metallo-toxicological and environmental studies 112
Review of cyclotron production and quality control of “high specific activity” radionuclides for biomedical, biological, industrial and environmental applications at INFN-LASA 111
Cyclotron production, Radiochemical separation and quality control of very high specific activity radiotracers for toxicological studies 110
Residual radioactivity at the Milan AVF cyclotron 109
Cyclotron production of N.C.A. copper-64 from deuteron irradiation on zinc target 107
MSCT and HEAT: computer codes for simulation of multiscattering and termal dissipation of charged particle beams in multiple thin metallic targets 104
Radiochemical quality control of [186Re]-HEDP for bone pain palliation 103
Determination of 90Sr impurities in [90Y]-labelled avidin-biotine for systemic radionuclide therapy, by liquid scintillation counting 98
Experimental thin-target and thick-target yields for natOs(alpha,xn)Pt, natOs(alpha,X)Os, Ir and natMo(p,xn)Tc nuclear reactions from threshold up to 38 and 45 MeV, by combined single and stacked foil techniques 93
Optimised cyclotron production of High Specific Activity technetium-95m,95g,96g,94g in the energy range up to 44 MeV: thin and thick target yields: radiochemical separation, quality control 92
Radioanalytical techniques based on the use of very High Specific Activity "No Carrier Added" radionuclides 89
Optimization of radionuclidic purity and Specific Activity of accelerator produced radionuclides Cu-64/Ga-66,67 84
Totale 10.945
Categoria #
all - tutte 26.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022663 0 34 28 39 57 35 79 46 71 81 60 133
2022/2023873 114 62 65 116 109 172 23 38 140 7 20 7
2023/2024534 17 39 38 29 82 48 14 36 10 99 52 70
2024/20251.350 41 109 12 135 214 52 27 144 42 65 83 426
2025/20262.500 237 112 245 161 279 172 253 148 340 279 96 178
2026/2027275 134 141 0 0 0 0 0 0 0 0 0 0
Totale 10.945